Symptomtext
No additional AE; an 18 month old female was administered VARIVAX in FEB 2022 and then inadvertently given PROQUAD on 24AUG2022 instead of the intended MMR II. Caller referred to PROQUAD as MMR V.; an 18 month old female was administered VARIVAX in FEB 2022 and then inadvertently given PROQUAD on 24AUG2022 instead of the intended MMR II. Caller referred to PROQUAD as MMR V.; This spontaneous report was received from a registered nurse and refers to an 18-month-old female patient. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On an unknown date in February 2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) (exact dose, strength, formulation, lot #, expiration date, site and route of administration were not provided) for prophylaxis. On 24-AUG-2022, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) (reported as "MMR V") lot #: U024510, expiration date: 02-FEB-2023 (exact dose, strength, formulation, site and route of administration were not provided) for prophylaxis; instead of intended dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (exact dose, strength, formulation, lot #, expiration date, albumin status, site and route of administration were not provided) for prophylaxis (wrong product administered; extra dose administered). There was no additional adverse event reported.